Listed by the USPTO as COFFA, SERGIO
Tech Center 1600 • Art Units: 1654 1658 1675 1676
This examiner grants 61% of resolved cases
COFFA, SERGIO is a USPTO patent examiner in tech center 1600 and art unit 1654. The profile includes 754 resolved cases, a 61.1% allowance rate, a 32.3% interview lift, and a median of 1069 days to allowance. The data supports treating interviews as a potentially useful prosecution tool while allowing for a moderate overall allowance outcome.
The listed companies are University of Florida Research Foundation Inc., Novo Nordisk A/S, and The Ohio State University. The listed firms are Clark+Elbing LLP, FOLEY & LARDNER LLP, and Meunier Carlin & Curfman LLC. The organizations indicate experience with university research and pharmaceutical matters.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18582271 | p53 VARIANT WITH IMPROVED LIQUID-LIQUID PHASE SEPARATION ABILITY AND ACTIVITY AND USE THEREOF | Non-Final OA | Zhejiang University |
| 18836118 | PEPTIDE HAVING ANTIBACTERIAL, ANTI-INFLAMMATORY OR TISSUE REGENERATION ABILITY AND USE THEREOF | Non-Final OA | Seoul National University R&DB Foundation |
| 17518047 | METHOD FOR TREATING OPIOID USE DISORDER | Final Rejection | The United States Government as represented by the Department of Veterans Affairs |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy61.1% of resolved applications examined by Sergio Coffa were allowed (754 resolved cases), compared with 48.5% across Art Unit 1654 over the last five years.
This examiner's interview lift is +32.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Sergio Coffa took 1,069 days on average from filing to allowance.
Sergio Coffa examines applications in Art Unit 1654 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
